DNB Fund-Health Care A (ACC) EUR

Reference Data

ISIN LU1660425346
Valor Number 37774288
Bloomberg Global ID
Fund Name DNB Fund-Health Care A (ACC) EUR
Fund Provider DNB Asset Management AS Stockholm, Sweden
Phone: +46 8 473 41 00
Web: www.cim.se
Fund Provider DNB Asset Management AS
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) Allfunds International Schweiz AG DZ Private Bank (schweiz) AG Fund Channel (Suisse) SA
Nyon 2
Phone: +4122 0000 Swissquote Bank
Gland
Phone: +41 22 999 94 11 UBS AG
Zürich
Phone: +41 44 234 11 11
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange.
Peculiarities

Fund Prices

Current Price * 17.67 EUR 31.12.2025
Previous Price * 17.63 EUR 30.12.2025
52 Week High * 18.22 EUR 06.02.2025
52 Week Low * 14.40 EUR 07.08.2025
NAV * 17.67 EUR 31.12.2025
Issue Price * 17.67 EUR 31.12.2025
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 113,356,933
Unit/Share Assets *** 170,651
Trading Information SIX

Performance

YTD Performance - -
YTD Performance (in CHF) - -
1 month +0.53% 01.12.2025
31.12.2025
3 months +15.07% 30.09.2025
31.12.2025
6 months +18.20% 30.06.2025
31.12.2025
1 year +4.16% 31.12.2024
31.12.2025
2 years +7.34% 02.01.2024
31.12.2025
3 years +7.32% 03.01.2023
31.12.2025
5 years +44.98% 31.12.2020
31.12.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 8.66%
Johnson & Johnson 6.33%
AstraZeneca PLC 6.32%
Roche Holding AG 6.20%
Novo Nordisk AS Class B 4.55%
UnitedHealth Group Inc 4.33%
Sanofi SA 3.84%
DexCom Inc 3.62%
Thermo Fisher Scientific Inc 3.38%
Lonza Group Ltd 3.33%
Last data update 30.11.2025

Cost / Risk

TER *** 1.572%
TER date *** 31.08.2025
Performance Fee *** 10.00%
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.57%
SRRI ***
SRRI date *** 31.12.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)